Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.56 | €4.00 | 56.250% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €39.80 | €50.00 | 25.628% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.97 | €5.51 | 469.102% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Centene Corp. | 15 | 0 | 3 | 0 | €71.48 | €82.57 | 15.516% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €85.25 | €100.00 | 17.302% |
| LivaNova plc | 9 | 0 | 3 | 0 | €57.00 | €66.59 | 16.829% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €99.50 | €124.85 | 25.475% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €3.00 | - | - |
| Stryker Corp. | 23 | 0 | 7 | 0 | €302.00 | €335.03 | 10.937% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €72.20 | €80.00 | 10.803% |
| Geron Corp. | 12 | 0 | 2 | 0 | €3.46 | €4.63 | 33.616% |
| Xencor Inc. | 10 | 1 | 2 | 0 | €22.60 | €32.58 | 44.154% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €76.00 | €75.94 | -0.084% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €71.50 | €79.00 | 10.490% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €212.60 | €248.57 | 16.919% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €189.00 | - | - |
| Lightpath Techs A | 4 | 0 | 1 | 0 | €1.32 | €2.78 | 110.955% |
| Cutera Inc. | 1 | 0 | 0 | 0 | €2.25 | €3.00 | 33.333% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.98 | €26.01 | 30.162% |
| Vitrolife AB | 3 | 0 | 0 | 0 | €15.09 | - | - |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €23.60 | €28.29 | 19.876% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €25.53 | €35.43 | 38.775% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.68 | €5.00 | 6.838% |